|
19
|
99
|
1k2bA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
17
|
99
|
1k6pA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
18
|
99
|
1k1tA |
Combining mutations in hiv-1 protease to understand mechanisms of resistance |
|
19
|
99
|
1k6tA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
65
|
210
|
1k6yA |
Crystal structure of a two-domain fragment of hiv-1 integrase |
|
18
|
99
|
1k6vA |
Lack of synergy for inhibitors targeting a multi-drug resistant hiv-1 protease |
|
111
|
435
|
1jlaB |
Crystal structure of y181c mutant hiv-1 reverse transcriptase in complex with tnk-651 |
|
137
|
558
|
1hnvA |
Structure of hiv-1 rt(slash)tibo r 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors |
|
16
|
99
|
1hxwA |
Hiv-1 protease dimer complexed with a-84538 |
|
14
|
99
|
1hteA |
X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of hiv-1 protease |
|
96
|
430
|
1hquB |
Human immunodeficiency virus type 1 |
|
17
|
99
|
1idaA |
Crystal structures of hiv-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere |
|
17
|
99
|
1hwrA |
Molecular recognition of cyclic urea hiv protease inhibitors |
|
14
|
99
|
1hshA |
Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (hiv) ii protease complexed with l-735,524, an orally bioavailable inhibitor of the hiv proteases |
|
122
|
556
|
1hpzA |
Human immunodeficiency virus type 1 |
|
135
|
554
|
1hqeA |
Human immunodeficiency virus type 1 |
|
17
|
99
|
1hosA |
Inhibition of human immunodeficiency virus-1 protease by a c2-symmetric phosphinate synthesis and crystallographic analysis |
|
16
|
99
|
1hvkA |
Influence of stereochemistry on activity and binding modes for c2 symmetry-based diol inhibitors of hiv-1 protease |
|
17
|
99
|
1hvlA |
Influence of stereochemistry on activity and binding modes for c2 symmetry-based diol inhibitors of hiv-1 protease |
|
13
|
99
|
1hsgA |
Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (hiv) ii protease complexed with l-735,524, an orally bioavailable inhibitor of the hiv proteases |
|
15
|
99
|
1hvrA |
Rational design of potent, bioavailable, nonpeptide cyclic ureas as hiv protease inhibitors |
|
14
|
99
|
1hsiA |
Crystal structure at 1.9 angstroms resolution of human immunodeficiency virus (hiv) ii protease complexed with l-735,524, an orally bioavailable inhibitor of the hiv proteases |
|
37
|
130
|
1hrhA |
Crystal structure of the ribonuclease h domain of hiv-1 reverse transcriptase |
|
100
|
427
|
1hniB |
Structure of hiv-1 reverse transcriptase in a complex with the nonnucleoside inhibitor alpha-apa r 95845 at 2.8 angstroms resolution |
|
16
|
99
|
1hvjA |
Influence of stereochemistry on activity and binding modes for c2 symmetry-based diol inhibitors of hiv-1 protease |
|
17
|
99
|
1hpxA |
Hiv-1 protease complexed with the inhibitor kni-272 |
|
13
|
99
|
1hpoA |
Hiv-1 protease triple mutant/u103265 complex |
|
17
|
99
|
1hxbA |
Hiv-1 proteinase complexed with ro 31-8959 |
|
16
|
99
|
1htgA |
X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of hiv-1 protease |
|
95
|
427
|
1hqeB |
Human immunodeficiency virus type 1 |
|
19
|
99
|
1hpvA |
Crystal structure of hiv-1 protease in complex with vx-478, a potent and orally bioavailable inhibitor of the enzyme |
|
91
|
427
|
1hnvB |
Structure of hiv-1 rt(slash)tibo r 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors |
|
18
|
99
|
1idbA |
Crystal structures of hiv-2 protease in complex with inhibitors containing the hydroxyethylamine dipeptide isostere |
|
125
|
556
|
1hquA |
Human immunodeficiency virus type 1 |
|
97
|
430
|
1hpzB |
Human immunodeficiency virus type 1 |
|
139
|
554
|
1hmvA |
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1 |
|
14
|
99
|
1hvsA |
Structural basis of drug resistance for the v82a mutant of hiv-1 protease: backbone flexibility and subsite repacking |
|
14
|
99
|
1hefE |
The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations |
|
18
|
99
|
1hvhA |
Nonpeptide cyclic cyanoguanidines as hiv protease inhibitors |
|
12
|
99
|
1hhpA |
The three-dimensional structure of the aspartyl protease from the hiv-1 isolate bru |
|
54
|
216
|
1harA |
2.2 angstroms resolution structure of the amino-terminal half of hiv-1 reverse transcriptase (fingers and palm subdomains) |
|
17
|
99
|
1hivA |
Crystal structure of a complex of hiv-1 protease with a dihydroethylene-containing inhibitor: comparisons with molecular modeling |
|
14
|
99
|
1hegE |
The crystal structures at 2.2 angstroms resolution of hydroxyethylene-based inhibitors bound to human immunodeficiency virus type 1 protease show that the inhibitors are present in two distinct orientations |
|
142
|
538
|
1klmA |
Hiv-1 reverse transcriptase complexed with bhap u-90152 |
|
16
|
99
|
1hihA |
Comparative analysis of the x-ray structures of hiv-1 and hiv-2 proteases in complex with cgp 53820, a novel pseudosymmetric inhibitor |
|
109
|
428
|
1klmB |
Hiv-1 reverse transcriptase complexed with bhap u-90152 |
|
40
|
115
|
1hiwA |
Trimeric hiv-1 matrix protein |
|
17
|
99
|
1hbvA |
A check on rational drug design. crystal structure of a complex of hiv-1 protease with a novel gamma-turn mimetic |
|
17
|
99
|
1htfA |
X-ray crystallographic studies of a series of penicillin-derived asymmetric inhibitors of hiv-1 protease |
|
104
|
423
|
1hmvB |
The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1 |
